A patient presented with symptoms and
Accepted 10 November 1989 necrosis after stereotactic radiosurgery for AVMs, affecting three of 135 patients treated in Sweden,'8 and this is the first report of radiation necrosis following AVM radiosurgery in the United Kingdom, documented with both radiology and histology.
Case report An eighteen year old girl presented in 1965 with sudden severe headache and drowsiness, while she was 36 weeks pregnant. She had a dense left hemiparesis and a temporal visual field deficit. Cerebral angiography showed an AVM in the region of the right basal ganglia, supplied by both anterior and middle cerebral arteries, with a small contribution from the posterior cerebral artery. She was not offered operation, and improved, but was left with a mild hemiparesis. Twenty two years later she developed sudden headache and worsening of the left hemiparesis. Computed tomography (CT) showed calcification in the region of the right basal ganglia, and haematoma extending into the lateral ventricle. Angiography showed a 14 mm by 22 mm by 30 mm AVM (fig la) . Operation was declined, and she was referred for stereotactic radiosurgery which was performed at the national centre in Sheffield. Two overlapping 14 mm collimator fields were used to deliver 25 Gray to the periphery of the lesion in a single dose. Three groups of brain reactions to external beam irradiation are described: acute reactions which occur during treatment; early delayed reactions which occur a few weeks to three months after completion of radiotherapy, and late delayed reactions which occur from several months to many years later.'6 Acute and early ' . 1 . There are many case reports of cerebral radiation necrosis following external beam radiotherapy, but few correlate the number of cases affected with the population treated. Risk factors for radiation necrosis include total dose, treatment time and dose fractions. Using these three parameters Ellis calculated a Nominal Standard Dose (NSD) to standardise the biological effect of different treatment regimes. This has been modified by various authors to estimate the threshold above which cerebral radiation necrosis occurs.2"2" Patient risk increases with higher dose, or the same dose given in a shorter period, or in fewer fractions. Stereotactic radiosurgery uses large doses of irradiation (up to 100 Gray) to small volumes of tissue (up to 30 mm diameter) in a single fraction. The dose per unit volume of tissue, even at the periphery of the lesion, is many times greater than that used in conventional external beam irradiation. This is likely to lead to more cases of brain necrosis, albeit confined to a small volume of tissue. The three previously reported cases received doses of more than 60 Gray to a single field, or more than 40 Gray to two overlapping fields. '9 The response of blood vessels to irradiation consists of reactive proliferation of the endothelial lining and subendothelial connective tissue, which may subsequently obliterate the lumen. This is the basis of the therapeutic effect of radiation on AVMs.'9 Similar vascular features are seen in delayed cerebral radiation necrosis; thickened vessel walls, endothelial proliferation, fibrinoid necrosis, hyaline and amyloid deposition, perivascular lymphocytic infiltration and intraluminal thrombosis in medium and small sized arteries. Parenchymal changes occur predominantly in white matter, and include coagulative necrosis, cystic cavitation with gliosis and patchy demyelination. The pathogenic mechanism is probably primarily vascular, with necrosis and glial loss secondary to ischaemia,2"124 but three other hypotheses have been proposed; direct injury to glial cells, particularly oligodendroglia, may produce white matter degeneration and demyelination,' an autoimmune reaction may result from endothelial damage (vasculitis) or glial antigen release following glial injury, or intracellular free radicles induced by radiation may damage lipid membranes, producing cell membrane dysfunction and cell death. 25 The development of a mass lesion at least three months after radiation treatment for an AVM is more likely to be due to radiation necrosis than a radiation induced intrinsic malignant tumour. There are only 17 With the increasing use of localised high dose radiotherapy, such as stereotactic radiosurgery, proton beam therapy, and interstitial brachytherapy, radiation necrosis will be seen more often. Careful follow up of all patients having treatment is important to determine the true incidence of radionecrosis; modification of treatment doses and volumes may be required. In the United Kingdom, patients with AVMs treated with radiosurgery are referred to a few specialised centres for treatment, but are followed up in peripheral units. It is important for those clinicians involved in the long term follow up of these patients to be familiar with the presentation and management of radiation necrosis, as the prognosis is relatively good if only small volumes of brain have been irradiated.
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